The Australian Competition and Consumer Commission says the fine imposed on Reckitt Benckiser should have been at least $6 million, not $1.7 million.
The consumer watchdog is appealing what it says is an inadequate fine imposed by the Federal Court against the makers of Nurofen over misplaced claims of targeted pain relief.
The Australian Competition and Consumer Commission says Reckitt Benckiser should have been fined at least $6 million, rather than the $1.7 million imposed, because the company made millions from products it misleadingly claimed were tailored to treat specific pain.
Click the podcast icon above to listen Korean news in detail.
Share
